Maryland · 2026 Regular Session · Bill
SB 435: Public Health - Medetomidine and Xylazine Consumer Protection Act
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
SB 435 is a bill introduced in the Maryland Senate on January 30, 2026. According to its official title, it concerns: Public Health - Medetomidine and Xylazine Consumer Protection Act. Primary sponsor: Bill Folden (Republican). Most recent recorded action (April 13, 2026): Motion Laid Over (Senator Ready) Adopted.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Sponsors
Sponsors by party (alphabetical): Republican 1
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Bill Folden | Primary sponsor | Republican | Senate | 4 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- Motion Laid Over (Senator Ready) Adopted
- Favorable with Amendments {
- Favorable with Amendments Report by Finance
- Hearing 2/11 at 2:00 p.m.
- First Reading Finance